Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924

被引：0

作者：

Andric, Z. ^{[1
]}

Ceric, T. ^{[2
]}

Stanetic, M. ^{[3
]}

Rancic, M. ^{[4
]}

Jakopovic, M. ^{[5
]}

Aix, S. Ponce ^{[6
]}

Ramlau, R. ^{[7
]}

Smit, E. ^{[8
]}

Ulanska, M. ^{[9
]}

Caldwell, C. ^{[10
]}

Ferrari, D. ^{[10
]}

Annis, A. ^{[11
]}

Vukovic, V. ^{[10
]}

Zaric, B. ^{[12
]}

机构：

[1] CHC Bezanijska Kosa, Med Oncol, Belgrade, Serbia

[2] Univ Clin Ctr Sarajevo, Med Oncol, Sarajevo, Bosnia & Herceg

[3] Univ Clin Ctr Lung Clin, Med Oncol, Banja Luka, Bosnia & Herceg

[4] Clin Pulm Dis Nis, Med Oncol, Nish, Serbia

[5] Clin Lung Dis Jordanovac, Med Oncol, Zagreb, Croatia

[6] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain

[7] Poznan Univ Med Sci, Med Oncol, Poznan, Poland

[8] Stichting Het Nederlands Kanker Inst, Med Oncol, Amsterdam, Netherlands

[9] Ctr Terapii Wspolczesnej, Med Oncol, Lodz, Poland

[10] Aileron Therapeut Inc, Clin Dev, Watertown, MA USA

[11] Aileron Therapeut Inc, Translat Res, Watertown, MA USA

[12] Inst Pulm Dis, Med Oncol, Novi Sad, Serbia

来源：

EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

96LBA

引用

页码：S5 / S5

页数：1

共 50 条

[21] A phase Ila clinical trial combining ALRN-6924 and palbociclib for the treatment of patients with tumours harboring wild -type p53 and MDM2 amplification or MDM2/CDK4 co-amplification
Meric-Bernstam, F.
Somaiah, N.
DuBois, S. G.
Dumbrava, E. E. Ileana
Shapiro, G. I.
Patel, M. R.
Goel, S.
Bauer, T.
Pinchasik, D.
Annis, A.
Aivado, M.
Vukovic, V.
Saleh, M.
[J]. ANNALS OF ONCOLOGY, 2019, 30 : 179 - +
[22] Phase I trial of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of WT p53 in patients with solid tumors and lymphomas.
Meric-Bernstam, Funda
Saleh, Mansoor N.
Infante, Jeffrey R.
Goel, Sanjay
Falchook, Gerald Steven
Shapiro, Geoffrey
Chung, Ki Y.
Conry, Robert Martin
Hong, David S.
Wang, Judy Sing-Zan
Steidl, Ulrich
Walensky, Loren D.
Guerlavais, Vincent
Payton, Marie
Annis, D. Allen
Aivado, Manuel
Patel, Manish R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[23] The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX
Muhammad, Ijaz
Rahman, Noor
Nayab, Gul E.
Niaz, Sadaf
Shah, Mohibullah
Afridi, Sahib Gul
Khan, Haroon
Daglia, Maria
Capanoglu, Esra
[J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2020, 15 (02) : 154 - 164
[24] Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma
Payton, M.
Pinchasik, D.
Mehta, A.
Goel, S.
Zain, J. M.
Sokol, L.
Jacobsen, E.
Patel, M. R.
Horwitz, S. M.
Meric-Bernstam, F.
Shustov, A.
Weinstock, D.
Aivado, M.
Annis, D. A.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[25] In Vitro andpre-Clinical In Vivo evidence Support MDMX/MDM2 As Common Vulnerabilities across TP53 -Wild-Type T-Cell Lymphomas That Are Targetable with the α-Helical p53 Stapled Peptide Alrn-6924
Koch, Raphael
Christie, Amanda L.
Yoshida, Noriaki
Ng, Samuel Y.
Shigemori, Kay
Morrow, Sara N.
Van Scoyk, Alexandria
Horwitz, Steven M.
Jacobsen, Eric
Santiago, Solimar
Ren, Jian-Guo
Guerlavais, Vincent
Annis, D. Allan
Aivado, Manuel A.
Weinstock, David M.
[J]. BLOOD, 2017, 130
[26] Burden of chemotherapy-induced myelosuppression among patients with ES-SCLC in US community oncology settings
Goldschmidt, Jerome
Monnette, Alisha
Shi, Ping
Venkatasetty, Divea
Lopez-Gonzalez, Lorena
Huang, Huan
[J]. FUTURE ONCOLOGY, 2022, 18 (35) : 3881 - 3894
[27] MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death
Barbieri, Eveline
Mehta, Parth
Chen, Zaowen
Zhang, Linna
Slack, Andrew
Berg, Stacey
Shohet, Jason M.
[J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (09) : 2358 - 2365
[28] Stapled α-helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
Chang, Yong S.
Graves, Bradford
Guerlavais, Vincent
Tovar, Christian
Packman, Kathryn
To, Kwong-Him
Olson, Karen A.
Kesavan, Kamala
Gangurde, Pranoti
Mukherjee, Aditi
Baker, Theresa
Darlak, Krzysztof
Elkin, Carl
Filipovic, Zoran
Qureshi, Farooq Z.
Cai, Hongliang
Berry, Pamela
Feyfant, Eric
Shi, Xiangguo E.
Horstick, James
Annis, D. Allen
Manning, Anthony M.
Fotouhi, Nader
Nash, Huw
Vassilev, Lyubomir T.
Sawyer, Tomi K.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (36) : E3445 - E3454
[29] FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2
Liu, T.
Xiong, J.
Yi, S.
Zhang, H.
Zhou, S.
Gu, L.
Zhou, M.
[J]. ONCOGENE, 2017, 36 (12) : 1678 - 1686
[30] FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2
T Liu
J Xiong
S Yi
H Zhang
S Zhou
L Gu
M Zhou
[J]. Oncogene, 2017, 36 : 1678 - 1686

← 1 2 3 4 5 →